TRAUMA YELLOW
  • Clinical
    • Discharge Macros
    • Procedure Macros
    • Exam Macros
    • Pediatric Macros
    • Antibiogram
    • Follow Up
    • 2023 MDM
    • Heart Pathway
    • Jeromy's Macros
  • Education
    • EM Education
    • Critical Care
    • FOAM
  • Orientation
    • Dept Orientation
    • Cerner
    • Dragon
  • Links
    • Clinical Links
    • StatMacros
    • ICU Bootcamp
  • Private
    • MCS
    • GWU Contacts & Map

Endocrine Emergencies: Ask the expert

4/26/2017

0 Comments

 
Picture
The down and dirty answers to life's most difficult endocrine questions

Thyroid Storm & Beta-blockers

Thyroid storm, a clinical diagnosis in patients with hyperthyroidism, presents with fevers, tachycardiac/atrial fibrillation, congestive heart failure, and agitations or seizures. Treatment typically includes beta-blockers for symptomatic control.

Should a patient in thyroid storm with heart failure receive beta-blockers? In patients who have heart failure secondary to thyroid storm, beta-blockers can significantly reduce cardiac index, and beta-blockers have been found to increase mortality in patients in acute thyroid storm, particularly propanolol. Theoretically, heart failure in thyroid storm is linked to increased heart rate, and patients presenting with mild to moderate heart failure may improve with a beta-blocker that has cardio-selective properties. If the etiology of heart failure is not secondary to the thyroid storm, beta-blockers should be used cautiously, starting with a short-acting BB such as Esmolol. Proanolol, which would have little cardiac effects comparatively, may be avoided. 

Methimazole vs. PTU

Both methimazole and propylthiouracil (PTU) are used to treat hyperthyroidism. Although less teratogenic, PTU has a blackbox warning for hepatotoxicity. Methimazole has less risk of hepatotoxicity, however is more teratogenic. To compare these drugs, Japanese researchers randomized 396 patients with Graves hyperthyroidism to receive 15 mg of methimazole once daily, 30 mg of methimazole daily (given as 15 mg twice daily), or 100 mg of PTU three times daily. Transaminase elevations and leukopenia occurred less commonly with both doses of methimazole than with PTU. Rash was less common with lower-dose methimazole than with higher-dose methimazole or PTU.

 A 2007 Journal Watch recommendation found that methimazole was superior overall, and lower doses seemed sufficient for patients with mild-to-moderate hyperthyroidism. Those who are pregnant should be considered for PTU therapy given the teratogenicity of methimazole.

Is bicarb level a reliable indicator of severity of DKA? 

Nah. Consider beta-hydroxybuterate levels if available in your hospital.

Should you bolus insulin in DKA patients? 

"Equivalence testing revealed no clinically relevant differences in IVF change, rate of change of glucose, or AG. Administration of an initial bolus dose of insulin was not associated with significant benefit to patients with DKA and demonstrated equivalent changes in clinically relevant endpoints when compared to patients not administered the bolus."
utility_of_insulin_bolus.pdf
File Size: 269 kb
File Type: pdf
Download File

0 Comments



Leave a Reply.

    Categories

     

    All
    Abx
    Article
    Cardiac
    EKG
    EKG Challenge
    GI Bleed
    Grand Rounds
    Headache
    ICU
    Orthopedic
    Pain
    Peds
    Reading
    Stroke
    Subarachnoid Hemorrhage
    Syncope
    Teaching Pearl
    Trauma
    Travel
    Zika

    Archive

     

    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    January 2016
    December 2015
    November 2015

    Picture
    Please read our Terms of Use.
Donate
This site is independently owned and operated and not affiliated with the George Washington University, George Washington University Hospital, or Medical Faculty Associates. All information on this site is the opinion of the author alone and in no way should be seen to represent the views of the George Washington University, George Washington University Hospital, or Medical Faculty Associates. The information on this page is for personal use only and should not be see as medical advice or used directly for patient care. The author provides no guarantee of the accuracy of the information provided on this page. ​

​Please refer to our Terms of Use. 
  • Clinical
    • Discharge Macros
    • Procedure Macros
    • Exam Macros
    • Pediatric Macros
    • Antibiogram
    • Follow Up
    • 2023 MDM
    • Heart Pathway
    • Jeromy's Macros
  • Education
    • EM Education
    • Critical Care
    • FOAM
  • Orientation
    • Dept Orientation
    • Cerner
    • Dragon
  • Links
    • Clinical Links
    • StatMacros
    • ICU Bootcamp
  • Private
    • MCS
    • GWU Contacts & Map